| __timestamp | GSK plc | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15683000000 | 2614539000 |
| Thursday, January 1, 2015 | 15070000000 | 3711019000 |
| Friday, January 1, 2016 | 18599000000 | 4560733000 |
| Sunday, January 1, 2017 | 19844000000 | 5475166000 |
| Monday, January 1, 2018 | 20580000000 | 6276700000 |
| Tuesday, January 1, 2019 | 21891000000 | 7081200000 |
| Wednesday, January 1, 2020 | 22395000000 | 7377200000 |
| Friday, January 1, 2021 | 22511000000 | 13634200000 |
| Saturday, January 1, 2022 | 19770000000 | 10612500000 |
| Sunday, January 1, 2023 | 21763000000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and GSK plc have shown distinct trajectories in gross profit. From 2014 to 2023, GSK's gross profit remained relatively stable, averaging around $20 billion annually, with a peak in 2021. In contrast, Regeneron experienced a remarkable growth, with its gross profit surging by over 400%, from approximately $2.6 billion in 2014 to $11.3 billion in 2023. This growth highlights Regeneron's strategic advancements and market adaptability. While GSK's consistent performance underscores its established market presence, Regeneron's rapid ascent reflects its innovative edge. As the pharmaceutical landscape continues to shift, these trends offer valuable insights into the financial health and strategic direction of these industry giants.
Gross Profit Comparison: Amgen Inc. and GSK plc Trends
Gross Profit Comparison: Sanofi and GSK plc Trends
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? GSK plc or Ascendis Pharma A/S
Gross Profit Analysis: Comparing GSK plc and Bausch Health Companies Inc.
Who Generates Higher Gross Profit? GSK plc or Travere Therapeutics, Inc.